First-Inventor-to-file: Protect Your Research Data

This FREE webinar was recorded on: Wednesday, May 23, 2012, 4:00 PM - 5:00 PM CET Sponsor Learn how to sponsor a webinar with us?

Join in Live May 23 from 10.00-11.00 AM EST ¦ 3.00-4.00pm UK Time

The Agilent OpenLAB ELN is used by global R&D labs that need to protect their Intellectual Property.

Electronic records are increasingly being used to support patent information and filing. Therefore, they need to be generated and managed with care. Technologies such as digital signatures and secure timestamping provide legally admissible digital evidence , but internal policies also need to be defined and followed (such as peer witness review workflows).

Understanding the new America Invents Act is key for both US-based companies and others who want to benefit from the huge US Market. Although the move to a “first-to-file” system simplifies the patent process, the need for admissible, credible and authenticated business records associated with your company’s intellectual property has not diminished. In fact, significant portions of the America Invents Act emphasize the importance of improved electronic records management best practices, including prior user defenses (Sec. 5, amending 35 U.S.C. § 273), derivation proceedings, and post-grant reviews.

This webinar will cover:

• What’s changing with the new America Invents Act
• How the USPTO handles electronic evidence
• What does a “first-inventor-to-file” mean?
• Why digital timestamping secures your applications and patents
• Learn how OpenLAB ELN helps you comply with these new regulations

Presenters:

Dr. Jon Roberts Senior Partner Marbury Law Group PLLC

Dr. Jon L. Roberts, Senior Partner of Marbury Law Group, PLLC, practices in security clearance law, patent, copyright, trademarks, and litigation related to these areas.  He is extensively involved in invention protection, business counseling, start-up advising, export control issues, qualifying personnel for security clearances, and helping companies deal with Foreign Ownership Control and Influence (FOCI) matters.  Dr. Roberts also provides litigation support to other law firms in the form of patent opinions, including appellate work, to clients in federal and state courts in all of these areas.  Dr. Roberts meets with patent and trademark examiners to resolve issues affecting approval of applications.

Dr. Roberts possesses active Security Clearances and regularly represents clients before Defense Office of Hearings and Appeals (DOHA) and other intelligence agency Administrative Boards regarding security clearances at all levels.  Dr. Roberts negotiates with senior level officials of U.S. Departments of State, Commerce, Treasury, and Defense regarding export applications and licenses.  He also interacts with senior level officials of Department of Justice and Office of U.S. Trade Representative to enforce client rights in intellectual property around the world.  Finally, Dr. Roberts is also extensively involved in software contracts (drafting and negotiation), and contract drafting concerning hardware and software development.

Dr. Roberts has extensive corporate and government agency experience.  He was a senior staff scientist and project director of a large government system integration project and discharged the responsibilities of principal research scientist in applications of artificial intelligence with General Electric Company, Space Systems Division.  His varied government agency experience includes managing numerous research efforts in the areas of software and hardware development, imaging systems, and mapping; high performance aircraft sensor system operator; image exploitation software development program manager; and interagency work related to remote sensing.

Francois Beillouin Product Manager ELN Agilent Technologies

Francois Beillouin, Product Manager ELN, Agilent Technologies: François Beillouin graduated from a French top-engineering school and holds a degree in Computer Science specialized in system and software architecture.  Over 10 years experience in ELN solutions deployment for large pharmaceutical and biotech company departments, gives him an in-depth understanding of solutions needed by customers in the Life Science industry.